These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Tau protein concentrations in cerebrospinal fluid of non-demented Parkinson's disease patients. Molina JA; Benito-León J; Jiménez-Jiménez FJ; Ortí-Pareja M; Berbel A; Tallón-Barranco A; de Bustos F; Hernánz A Neurosci Lett; 1997 Dec; 238(3):139-41. PubMed ID: 9464639 [TBL] [Abstract][Full Text] [Related]
13. Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease. Férnandez-Calle P; Molina JA; Jiménez-Jiménez FJ; Vázquez A; Pondal M; García-Ruiz PJ; Urra DG; Domingo J; Codoceo R Neurology; 1992 May; 42(5):1064-6. PubMed ID: 1579230 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease. Jiménez-Jiménez FJ; Molina JA; Aguilar MV; Meseguer I; Mateos-Vega CJ; González-Muñoz MJ; de Bustos F; Martínez-Salio A; Ortí-Pareja M; Zurdo M; Martínez-Para MC J Neural Transm (Vienna); 1998; 105(4-5):497-505. PubMed ID: 9720977 [TBL] [Abstract][Full Text] [Related]
15. Serum levels of vitamin A in Parkinson's disease. Jiménez-Jiménez FJ; Molina JA; Fernández-Calle P; Vázquez A; Pondal M; del Ser T; Gómez-Pastor A; Codoceo R J Neurol Sci; 1992 Aug; 111(1):73-6. PubMed ID: 1403000 [TBL] [Abstract][Full Text] [Related]
16. Serum levels of zinc and copper in patients with Parkinson's disease. Jiménez-Jiménez FJ; Fernández-Calle P; Martínez-Vanaclocha M; Herrero E; Molina JA; Vázquez A; Codoceo R J Neurol Sci; 1992 Oct; 112(1-2):30-3. PubMed ID: 1469436 [TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson's disease. Molina JA; de Bustos F; Jiménez-Jiménez FJ; Benito-León J; Ortí-Pareja M; Gasalla T; Tallón-Barranco A; Navarro JA; Arenas J; Enríquez-de-Salamanca R J Neural Transm (Vienna); 1997; 104(11-12):1287-93. PubMed ID: 9503274 [TBL] [Abstract][Full Text] [Related]
18. Plasma levels of lipid peroxides in patients with Parkinson's disease. Sanyal J; Bandyopadhyay SK; Banerjee TK; Mukherjee SC; Chakraborty DP; Ray BC; Rao VR Eur Rev Med Pharmacol Sci; 2009; 13(2):129-32. PubMed ID: 19499848 [TBL] [Abstract][Full Text] [Related]
19. The neurotoxicity of iron, copper and cobalt in Parkinson's disease through ROS-mediated mechanisms. Lan AP; Chen J; Chai ZF; Hu Y Biometals; 2016 Aug; 29(4):665-78. PubMed ID: 27349232 [TBL] [Abstract][Full Text] [Related]
20. Normal cerebrospinal fluid levels of insulin in patients with Parkinson's disease. Jiménez-Jiménez FJ; Molina JA; Vargas C; Gómez P; De Bustos F; Zurdo M; Gómez-Escalonilla C; Barcenilla B; Berbel A; Camacho A; Arenas J J Neural Transm (Vienna); 2000; 107(4):445-9. PubMed ID: 11215755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]